Responses
Dermatology
Protocol
Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment
Compose a Response to This Article
Other responses
No responses have been published for this article.